Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study

<p>Abstract</p> <p>Background</p> <p>Despite the high frequency with which adverse drug events (ADEs) occur in outpatient settings, detailed information regarding these events remains limited. Anticoagulant drugs are associated with increased safety concerns and are com...

Full description

Bibliographic Details
Main Authors:	Eckstrand Julie, Cozart Heidi, Horvath Monica M, Bendz Lisa, Long Andrea L, Whitehurst Julie, Ferranti Jeffrey
Format:	Article
Language:	English
Published:	BMC 2010-02-01
Series:	Thrombosis Journal
Online Access:	http://www.thrombosisjournal.com/content/8/1/5

Similar Items

Computerized surveillance of opioid-related adverse drug events in perioperative care: a cross-sectional study
by: Gattis Katherine G, et al.
Published: (2009-08-01)

Towards the creation of a flexible classification scheme for voluntarily reported transfusion and laboratory safety events
by: Whitehurst Julie M, et al.
Published: (2012-05-01)

A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19
by: Purva Patel, et al.
Published: (2023-03-01)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
by: Julia C. Cambron, BS, et al.
Published: (2020-06-01)

UTILIZATION OF DRUGS AMONG USERS OF AMBULATORY’S DIABETES: A DESCRIPTIVE STUDY
by: Vivian Saraiva Veras, et al.
Published: (2011-04-01)

UTILIZATION OF DRUGS AMONG USERS OF AMBULATORY’S DIABETES: A DESCRIPTIVE STUDY
by: Vivian Saraiva Veras, et al.
Published: (2011-04-01)

UTILIZATION OF DRUGS AMONG USERS OF AMBULATORY’S DIABETES: A DESCRIPTIVE STUDY
by: Vivian Saraiva Veras, et al.
Published: (2011-04-01)

UTILIZATION OF DRUGS AMONG USERS OF AMBULATORY’S DIABETES: A DESCRIPTIVE STUDY
by: Vivian Saraiva Veras, et al.
Published: (2011-04-01)

Adverse drug events: description of an active search process in a teaching hospital of the Sentinela Network
by: Wanessa S. NOGUEIRA, et al.
Published: (2021-03-01)

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.
by: Wan, Y, et al.
Published: (2008)

Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions
by: Verbič Matej Dobravc, et al.
Published: (2023-06-01)

Adverse events among high-risk participants in a home-based walking study: a descriptive study
by: Holleman Robert G, et al.
Published: (2007-05-01)

Cost-effectiveness of new oral anticoagulants and warfarin in atrial fibrillation from adverse events perspective
by: José A. Mendoza, et al.
Published: (2019-03-01)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
by: Kaito Yamashiro, et al.
Published: (2022-10-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021-08-01)

An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
by: Kai-li Liang, et al.
Published: (2022-06-01)

Safety Profile of Ambulatory Prostatic Artery Embolization after a Significant Learning Curve: Update on Adverse Events
by: Gregory Amouyal, et al.
Published: (2022-07-01)

Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023-10-01)

Direct Oral Anticoagulants as the First Choice of Anticoagulation for Patients with Peripheral Artery Disease to Prevent Adverse Vascular Events: A Systematic Review and Meta-Analysis
by: Enikő Pomozi, et al.
Published: (2023-02-01)

Adverse Drug Events after Kidney Transplantation
by: Lionel Rostaing, et al.
Published: (2023-12-01)

Adverse Event Circumstances and the Case of Drug Interactions
by: Theodoros G. Soldatos, et al.
Published: (2019-03-01)

Contraindications and adverse events of drugs in cardioneurological patients.
by: Ol'ga Gennadievna Kompaniets
Published: (2009-09-01)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-05-01)

Development of an adverse drug event network to predict drug toxicity
by: Qier Wu, et al.
Published: (2020-06-01)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-07-01)

Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort
by: Matteo Candeloro, et al.
Published: (2022-02-01)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
by: Natalia A. Shnayder, et al.
Published: (2021-04-01)

Analysis of burden and outcomes of anticoagulant induced adverse drug effects at a tertiary care centre
by: Arnav H Tongaonkar, et al.
Published: (2023-01-01)

Doxycycline use and adverse pregnancy or neonatal outcomes: A descriptive study using the United States Food and Drug Administration Adverse Event Reporting System database
by: Sammodavardhana Kaundinnyayana, et al.
Published: (2022-11-01)

Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription
by: Maral Koolian, et al.
Published: (2022-08-01)

Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps
by: Julie Kelly, et al.
Published: (2021-06-01)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
by: Christine Learned, BA, et al.
Published: (2022-06-01)

The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results.
by: Cecilia Portugal, et al.
Published: (2022-01-01)

The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results
by: Cecilia Portugal, et al.
Published: (2022-01-01)

Trends of ambulatory oral anticoagulant prescription in five major cities of China, 2012–2017
by: Zhenwei Yu, et al.
Published: (2020-03-01)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
by: Joshua D. Brown
Published: (2020-03-01)

Dentistry and Drug Adverse Events: Between Responsibilities and Regulations
by: Tommaso D’Anna, et al.
Published: (2022-11-01)

Variation in adverse drug events of opioids in the United States
by: Edward Y. Liu, et al.
Published: (2023-03-01)

Reducing preventable adverse drug events in hospital settings
by: Ramos, Gregg (Gregg Allen)
Published: (2008)

Inappropriate prescribing and adverse drug events in older people
by: Gallagher Paul F, et al.
Published: (2009-01-01)